332 related articles for article (PubMed ID: 31835128)
1. Iron homeostasis is dysregulated, but the iron-hepcidin axis is functional, in chronic liver disease.
Varghese J; Varghese James J; Karthikeyan M; Rasalkar K; Raghavan R; Sukumaran A; Premkumar PS; Eapen CE; Jacob M
J Trace Elem Med Biol; 2020 Mar; 58():126442. PubMed ID: 31835128
[TBL] [Abstract][Full Text] [Related]
2. Adaptation of iron transport and metabolism to acute high-altitude hypoxia in mountaineers.
Goetze O; Schmitt J; Spliethoff K; Theurl I; Weiss G; Swinkels DW; Tjalsma H; Maggiorini M; Krayenbühl P; Rau M; Fruehauf H; Wojtal KA; Müllhaupt B; Fried M; Gassmann M; Lutz T; Geier A
Hepatology; 2013 Dec; 58(6):2153-62. PubMed ID: 23787477
[TBL] [Abstract][Full Text] [Related]
3. Increased Duodenal Iron Absorption through Upregulation of Ferroportin 1 due to the Decrement in Serum Hepcidin in Patients with Chronic Hepatitis C.
Sato M; Miyanishi K; Tanaka S; Sakurada A; Sakamoto H; Kawano Y; Takada K; Kobune M; Kato J
Can J Gastroenterol Hepatol; 2018; 2018():2154361. PubMed ID: 30186818
[TBL] [Abstract][Full Text] [Related]
4. Age-dependent expression of duodenal cytochrome b, divalent metal transporter 1, ferroportin 1, and hephaestin in the duodenum of rats.
Kong WN; Wu Q; Shen D; Zhao SE; Guo P; Duan XL; Chang YZ
J Gastroenterol Hepatol; 2015 Mar; 30(3):513-20. PubMed ID: 25318588
[TBL] [Abstract][Full Text] [Related]
5. Expression of iron-related proteins in the duodenum is up-regulated in patients with chronic inflammatory disorders.
Sukumaran A; James J; Janardhan HP; Amaladas A; Suresh LM; Danda D; Jeyeseelan V; Ramakrishna BS; Jacob M
Br J Nutr; 2014 Mar; 111(6):1059-68. PubMed ID: 24160450
[TBL] [Abstract][Full Text] [Related]
6. Inflammation neither increases hepatic hepcidin nor affects intestinal (59)Fe-absorption in two murine models of bowel inflammation, hemizygous TNF(ΔARE/+) and homozygous IL-10(-/-) mice.
Buffler M; Becker C; Windisch W; Schümann K
J Trace Elem Med Biol; 2015 Oct; 32():162-7. PubMed ID: 26302924
[TBL] [Abstract][Full Text] [Related]
7. Decreased hepatic iron in response to alcohol may contribute to alcohol-induced suppression of hepcidin.
Varghese J; James JV; Sagi S; Chakraborty S; Sukumaran A; Ramakrishna B; Jacob M
Br J Nutr; 2016 Jun; 115(11):1978-86. PubMed ID: 27080262
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II alters the expression of duodenal iron transporters, hepatic hepcidin, and body iron distribution in mice.
Tajima S; Ikeda Y; Enomoto H; Imao M; Horinouchi Y; Izawa-Ishizawa Y; Kihira Y; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
Eur J Nutr; 2015 Aug; 54(5):709-19. PubMed ID: 25096756
[TBL] [Abstract][Full Text] [Related]
9. Hepcidin levels in children with chronic liver disease.
Cakir M; Erduran E; Turkmen ES; Aliyazicioglu Y; Reis GP; Cobanoglu U; Demir S
Saudi J Gastroenterol; 2015; 21(5):300-5. PubMed ID: 26458857
[TBL] [Abstract][Full Text] [Related]
10. Serum hepcidin levels in patients with end-stage renal disease on hemodialysis.
Rubab Z; Amin H; Abbas K; Hussain S; Ullah MI; Mohsin S
Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):19-25. PubMed ID: 25579711
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow iron distribution, hepcidin, and ferroportin expression in renal anemia.
Bârsan L; Stanciu A; Stancu S; Căpuşă C; Brătescu L; Mandache E; Radu E; Mircescu G
Hematology; 2015 Oct; 20(9):543-52. PubMed ID: 25745821
[TBL] [Abstract][Full Text] [Related]
12. Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C.
Fujita N; Sugimoto R; Takeo M; Urawa N; Mifuji R; Tanaka H; Kobayashi Y; Iwasa M; Watanabe S; Adachi Y; Kaito M
Mol Med; 2007; 13(1-2):97-104. PubMed ID: 17515961
[TBL] [Abstract][Full Text] [Related]
13. Hepcidin and proinflammatory markers in children with chronic kidney disease: A case-control study
.
Goyal KK; Saha A; Sahi PK; Kaur M; Dubey NK; Goyal P; Upadhayay AD
Clin Nephrol; 2018 May; 89(5):363-370. PubMed ID: 29451472
[TBL] [Abstract][Full Text] [Related]
14. Ferroportin-Hepcidin Axis in Prepubertal Obese Children with Sufficient Daily Iron Intake.
Gajewska J; Ambroszkiewicz J; Klemarczyk W; Głąb-Jabłońska E; Weker H; Chełchowska M
Int J Environ Res Public Health; 2018 Oct; 15(10):. PubMed ID: 30275363
[TBL] [Abstract][Full Text] [Related]
15. Sex differences in iron status and hepcidin expression in rats.
Kong WN; Niu QM; Ge L; Zhang N; Yan SF; Chen WB; Chang YZ; Zhao SE
Biol Trace Elem Res; 2014 Aug; 160(2):258-67. PubMed ID: 24962641
[TBL] [Abstract][Full Text] [Related]
16. Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease.
Marmur J; Beshara S; Eggertsen G; Onelöv L; Albiin N; Danielsson O; Hultcrantz R; Stål P
BMC Gastroenterol; 2018 Jun; 18(1):78. PubMed ID: 29871592
[TBL] [Abstract][Full Text] [Related]
17. Increased serum iron in preeclamptic women is likely due to low hepcidin levels.
Brunacci F; Rocha VS; De Carli E; Espósito BP; Ruano R; Colli C
Nutr Res; 2018 May; 53():32-39. PubMed ID: 29685625
[TBL] [Abstract][Full Text] [Related]
18. Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease.
Ueda N; Takasawa K
Nutrients; 2018 Aug; 10(9):. PubMed ID: 30150549
[TBL] [Abstract][Full Text] [Related]
19. Serum hepcidin concentrations correlate with ferritin in patients with inflammatory bowel disease.
Mecklenburg I; Reznik D; Fasler-Kan E; Drewe J; Beglinger C; Hruz P;
J Crohns Colitis; 2014 Nov; 8(11):1392-7. PubMed ID: 24825446
[TBL] [Abstract][Full Text] [Related]
20. Targeting the hepcidin-ferroportin pathway in anaemia of chronic kidney disease.
Sheetz M; Barrington P; Callies S; Berg PH; McColm J; Marbury T; Decker B; Dyas GL; Truhlar SME; Benschop R; Leung D; Berg J; Witcher DR
Br J Clin Pharmacol; 2019 May; 85(5):935-948. PubMed ID: 30677788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
